Literature DB >> 15907222

Biological activities of isatin and its derivatives.

Surendra Nath Pandeya1, Sivakumar Smitha, Mayank Jyoti, Seshaiah Krishnan Sridhar.   

Abstract

Isatin is an endogenous compound identified in humans that possesses a wide range of biological activities. Isatin has anxiogenic, sedative, anticonvulsant activities and acts as a potent antagonist on atrial natriuretic peptide receptors in vitro. A series of p-substituted isatin semicarbazones have shown anticonvulsant activity in MES, scPTZ and scSTY tests. Various isatin-N-Mannich bases of isatin-3-thiosemicarbazones have shown antiviral and tuberculostatic activity. Methisazone is an effective compound against variola and vaccinia viruses. The N-dimethyl and morpholino derivative of 5-methyl isatin and trimethoprim exhibited an EC50 of more than 4.3 and 17.7 mg mL(-1), respectively. Isatin (3-o-nitrophenyl) hydrazone has shown activity against Walker carcinoma-256. Various substituted indolinones showed antitubercular activity against M. tuberculosis H37Rv with MIC ranging from 10-20 microg mL(-1). Isatin derivatives of Mannich bases had fibrinolytic, muscle relaxant, antiallergic, immunosuppressant, and antithrombotic activity. Isatin showed cardioinhibitory effect on frog heart, and hypotensive, respiratory depression and antidiuretic effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15907222

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  43 in total

1.  Synthesis and biological evaluation of a novel class of isatin analogs as dual inhibitors of tubulin polymerization and Akt pathway.

Authors:  Gowdahalli Krishnegowda; A S Prakasha Gowda; Hephzibah Rani S Tagaram; Kevin F Staveley-O' Carroll; Rosalyn B Irby; Arun K Sharma; Shantu Amin
Journal:  Bioorg Med Chem       Date:  2011-08-26       Impact factor: 3.641

2.  Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.

Authors:  Cornelius Klöck; Xi Jin; Kihang Choi; Chaitan Khosla; Peter B Madrid; Andrew Spencer; Brian C Raimundo; Paul Boardman; Guido Lanza; John H Griffin
Journal:  Bioorg Med Chem Lett       Date:  2010-12-16       Impact factor: 2.823

3.  Anticonvulsant activity, molecular modeling and synthesis of spirooxindole-4H-pyran derivatives using a novel reusable organocatalyst.

Authors:  Leila Emami; Leila Moezi; Leila Amiri-Zirtol; Fatemeh Pirsalami; Masoumeh Divar; Aida Solhjoo; Soghra Khabnadideh
Journal:  Mol Divers       Date:  2022-01-25       Impact factor: 2.943

4.  Isatin-induced increase in the affinity of human ferrochelatase and adrenodoxin reductase interaction.

Authors:  Pavel Ershov; Yuri Mezentsev; Andrey Gilep; Sergey Usanov; Olga Buneeva; Alexei Medvedev; Alexis Ivanov
Journal:  Protein Sci       Date:  2017-10-09       Impact factor: 6.725

5.  3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-5-yl)-5-fluoro-3-hydr-oxy-1-methyl-indolin-2-one methanol hemisolvate.

Authors:  Narsimha Reddy Penthala; Thirupathi Reddy Yerram Reddy; Sean Parkin; Peter A Crooks
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-31

6.  3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-5-yl)-3-hydr-oxy-1-phenyl-indolin-2-one ethanol solvate.

Authors:  Narsimha Reddy Penthala; Thirupathi Reddy Yerram Reddy; Sean Parkin; Peter A Crooks
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-09-12

7.  Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole-Indole Hybrids.

Authors:  Ashraf S Hassan; Gaber O Moustafa; Hanem M Awad; Eman S Nossier; Mohamed F Mady
Journal:  ACS Omega       Date:  2021-04-29

8.  Synthesis and characterization of new Schiff bases derived from N (1)-substituted isatin with dithiooxamide and their Co(II), Ni(II), Cu(II), Pd(II), and Pt(IV) complexes.

Authors:  Ahlam J Abdul-Ghani; Asmaa M N Khaleel
Journal:  Bioinorg Chem Appl       Date:  2009-10-26       Impact factor: 7.778

9.  Biological targets for isatin and its analogues: Implications for therapy.

Authors:  Alexei Medvedev; Olga Buneeva; Vivette Glover
Journal:  Biologics       Date:  2007-06

10.  Novel piperazine based compounds as potential inhibitors for SARS-CoV-2 Protease Enzyme: Synthesis and molecular docking study.

Authors:  Alaa Z Omar; Tawfik M Mosa; Samer K El-Sadany; Ezzat A Hamed; Mohamed El-Atawy
Journal:  J Mol Struct       Date:  2021-07-04       Impact factor: 3.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.